KCNA5 and pulmonary arterial hypertension: Common single-nucleotide polymorphisms in coding and non-coding regions of KCNA5 have been reported with increased frequency in PAH cases compared to controls [47,48,49], suggesting that KCNA5 variants could modulate PAH onset and severity.